Skip to main content
. 2023 Aug 4;12(8):1285. doi: 10.3390/antibiotics12081285

Figure 5.

Figure 5

Susceptibility of KPC-producing Klebsiella pneumoniae isolated during COVID-19 pandemic. SPZ cefoperazone–sulbactam, MEM meropenem, GEN gentamicin, TOB tobramycin, AMI amikacin, CIP ciprofloxacin, TET tetracycline, TGC tigecycline, COT co-trimoxazole (trimethoprim–sulfamethoxazole), COL colistin. All isolates were resistant to ampicillin (intrinsic resistance); ampicillin–sulbactam, piperacillin–tazobactam, cefuroxime, cefotaxime, ceftazidime, cefepime, and ertapenem.